Studies have shown that ANO1 is significantly overexpressed in epithelial ovarian cancer cells, with its upregulation strongly associated with higher FIGO (International Federation of Gynecology and Obstetrics) stages and lower differentiation grades (168). This evidence concerns the gene ANO1 and ovarian carcinoma.